Product | Prick, mm | Intradermal, mm | Result |
---|---|---|---|
Histamine | 4,8 | 10,21 | Positive control |
Diluent control | 0,0 | 0,0 | Negative control |
Midazolam, 0.5 mg/mL | 0,0 | Negative | |
Midazolam, 1:100 | 0,0 | Negative | |
Midazolam, 1:10 | 0,0 | Negative | |
Fentanyl, 0.05 mg/mL | 0,0 | Negative | |
Fentanyl, 1:1,000 | 0,0 | Negative | |
Fentanyl, 1:100 | 0,0 | Negative | |
Propofol, 10 mg/mL | 0,0 | Negative | |
Propofol, 1:100 | 0,0 | Negative | |
Propofol, 1:10 | 0,0 | Negative | |
Cefazolin, 330 mg/mL | 0,0 | Negative | |
Cefazolin, 1:100 | 0,0 | Negative | |
Cefazolin, 1:10 | 0,0 | Negative | |
PRE-PEN (benzylpenicilloyl polylysine: 10,000 U/mL) | 0,0 | 0,0 | Negative |
Penicillin G, (benzylpenicillin: 10,000 U/mL) | 0,0 | 0,0 | Negative |
Lidocaine 2%, 20 mg/mL | 0,0 | Negative | |
Lidocaine, 1:100 | 0,0 | Negative | |
aIsosulfan blue 1%, 10 mg/mL | 6,8 | Positive | |
aIsosulfan blue 1%, 10 mg/mL | 5,5 | Positive | |
Isosulfan blue, 1:10,000 | 0,0 | Negative | |
Isosulfan blue, 1:1,000 | 11,22 | Positive |
Note: Table shows negative skin testing to PRE-PEN and Penicillin G via intradermal and percutaneous methods with appropriate positive and negative controls. The patient tested negative to midazolam, fentanyl, propofol, cefazolin, and lidocaine but positive to isosulfan blue.
↵aTest was repeated to confirm reaction to isosulfan blue.